Troy Edward Wilson Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 month, 3 weeks ago
Troy Edward Wilson has an estimated net worth of at least $13.0 million*, as of Aug. 6, 2025. They own 72,201 shares of RNA stock. They have sold 370,627 shares of RNA stock since 2021, for an estimated $0.
Troy Edward Wilson $RNA SEC Form 4 Insider Trading
Troy Edward Wilson has filed a total of 8 insider trades in $RNA since 2021. Their most recent trade was a sale of 14,500 shares, made on Sep 05, 2025. Their largest trade was a sale of 22,000 shares, made on Aug 06, 2025. We estimate that they now own 72,201 shares of $RNA, worth an estimated $13.0 million.
Insider Trading at $RNA
There have been a total of 139 insider trades reported at $RNA since 2021, with 800,000 shares purchased and 2.8 million shares sold. The most active insider traders in $RNA stock have been Sarah Boyce, Arthur A Levin, and Michael F Maclean. The most recent trade was a sale of 2,208 shares reported by Steven George Hughes (Chief Medical Officer), made on Sep 22, 2025.
History of Insider Stock Trades by Troy Edward Wilson
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
KURA
|
Sale | 36,615 | Sep 29, 2025 | Sept. 29, 2025, 7:30 p.m. |
RNA
|
Sale | 14,500 | Sep 05, 2025 | Sept. 9, 2025, 5:53 p.m. |
|
RNA
|
Sale | 15,000 | Sep 05, 2025 | Sept. 9, 2025, 5:53 p.m. |
|
KURA
|
Purchase | 50,000 | Sep 08, 2025 | Sept. 9, 2025, 4:28 p.m. |
|
KURA
|
Purchase | 36,506 | Aug 12, 2025 | Aug. 14, 2025, 4:05 p.m. |
|
KURA
|
Purchase | 13,494 | Aug 13, 2025 | Aug. 14, 2025, 4:05 p.m. |
|
RNA
|
Sale | 22,000 | Aug 06, 2025 | Aug. 8, 2025, 5:42 p.m. |
|
RNA
|
Sale | 7,500 | Aug 06, 2025 | Aug. 8, 2025, 5:42 p.m. |
|
RNA
|
Sale | 15,000 | Aug 06, 2025 | Aug. 8, 2025, 5:42 p.m. |
|
RNA
|
Sale | 15,000 | Aug 06, 2025 | Aug. 8, 2025, 5:42 p.m. |
|
RNA
|
Sale | 17,777 | Aug 06, 2025 | Aug. 8, 2025, 5:42 p.m. |
|
RNA
|
Sale | 17,777 | Aug 06, 2025 | Aug. 8, 2025, 5:42 p.m. |
PBYI
|
Sale | 10,800 | Jun 13, 2025 | June 17, 2025, 7:55 p.m. |
|
PBYI
|
Sale | 27,000 | Jun 13, 2024 | June 17, 2024, 7:27 p.m. |
|
KURA
|
Sale | 6,945 | Jan 24, 2024 | Jan. 26, 2024, 6:10 p.m. |
|
KURA
|
Sale | 84,107 | Jan 24, 2024 | Jan. 26, 2024, 6:10 p.m. |
|
PBYI
|
Sale | 27,000 | Jun 13, 2023 | June 15, 2023, 9:14 p.m. |
|
PBYI
|
Sale | 27,858 | Jun 16, 2022 | June 21, 2022, 7:12 p.m. |
|
PBYI
|
Sale | 25,748 | Jun 10, 2021 | June 10, 2021, 8 p.m. |
$RNA Executives and Stock Owners with Insider Trades
-
Sarah Boyce, President and CEO
-
Arthur A Levin, Chief Scientific Officer
-
Michael F Maclean, Chief Financial Officer
-
Teresa Mccarthy, Chief Human Resources Officer
-
Kathleen P. Gallagher, Chief Program Officer
-
Steven George Hughes, Chief Medical Officer
-
W. Michael Flanagan, CSTO
-
W. Michael Flanagan, Chief Scientific Officer
-
Eric Mosbrooker, Chief Commercial Officer
-
John B Moriarty, Chief Legal Officer
-
Roderick Wong, MP and CIO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.